Cytospire TherapeuticsListed
cytospiretherapeutics.combiotech_life_sciences
Cytospire Therapeutics is a biopharmaceutical company focused on developing innovative therapies.
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Cytospire Therapeutics is a biopharmaceutical company focused on developing innovative therapies.
Ray Therapeutics is a clinical-stage biotechnology company developing best-in-class vision restoration therapies for people with degenerative retinal diseases independent of genet…
Contract development and manufacturing organization (CDMO) supporting advanced therapy developers from research through commercialization. Provides process and analytical developm…
SparingVision is a clinical-stage genomic medicines company focused on developing innovative treatments for ocular diseases, particularly inherited retinal diseases (IRDs) such as…
Araris Biotech AG is pioneering the development of a novel, proprietary antibody-drug conjugate (ADC)-linker technology that enables the attachment of payloads to 'off-the-shelf'…
Biotechnology company discovering, developing, and commercializing ex vivo autologous hematopoietic stem cell (HSC) gene therapies for rare, genetic, and other severe diseases. It…
ADC Therapeutics is a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs) advancing proprietary ADC technology to transform the treatment pa…
Developing CAR T cell therapies for patients with cancer and autoimmune diseases.
uniQure is a global leader in gene therapy, delivering innovative cures that transform lives through an AAV-based technology platform. The company focuses on treating serious unme…
Entact Bio is pioneering precision medicines that enhance the function of beneficial proteins, targeting previously undruggable pathways and addressing hard-to-treat genetic disor…
Details are not available yet. The company remains listed.
Details are not available yet. The company remains listed.
Trogenix is a pioneering biotech company dedicated to developing innovative cancer therapies through its proprietary Odysseus® platform, which targets cancer cells to deliver prec…
Actithera is a biotech company focused on developing targeted radioligand therapies for cancer, aiming to deliver personalized treatments with fewer side effects.
Details are not available yet. The company remains listed.
Biotechnology company developing treatments for Epstein-Barr virus (EBV)-driven diseases. It uses precision engineering of immune-cell metabolism to alter specific cellular states…
Biotechnology company developing non-viral gene-editing technologies and advanced gene therapies intended to make cell and gene therapies safer, more effective, scalable, and acce…
ViaNautis Bio develops polyNaut®, a non-viral, targeted polymer-based nanovesicle delivery platform for genetic medicines and cell and gene therapies. Its platform is designed for…
Carisma Therapeutics is a biopharmaceutical company dedicated to developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that pl…
Egalet was a fully integrated specialty pharmaceutical company developing, manufacturing, and commercializing medicines for acute and chronic pain. Its products included abuse-det…
Ann Arbor biotechnology company developing a sight-restoration therapy. It was acquired by Allergan for $60 million in 2016.
Seres Therapeutics is a clinical stage biotechnology company developing new therapies comprised of rationally selected live bacteria consortia to modulate the human microbiome and…
Estuary Biotherapeutics is focused on developing genetic medicines to treat autosomal dominant polycystic kidney disease (ADPKD) by addressing the underlying genetic causes of the…
A Cambridge-based platform biotechnology company developing targeted delivery of siRNA therapeutics. Its DELiveri platform uses AI to identify and optimize conjugates that direct…
Aptadir Therapeutics S.R.L. develops biotechnology solutions focused on RNA therapeutics to reprogram DNA methylation. The Company conducts preclinical research and drug discovery…
Early-stage therapeutics company developing engineered tRNA-based RNA therapeutics for cancer. Its platform selectively and durably inhibits multiple RNA-modifying enzymes that ca…